STOCK TITAN
  1. Home
  2. News
  3. IQV

IQVIA Holdings Inc - IQV STOCK NEWS

Welcome to our dedicated news page for IQVIA Holdings (Ticker: IQV), a resource for investors and traders seeking the latest updates and insights on IQVIA Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect IQVIA Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of IQVIA Holdings's position in the market.

News
IQVIA Digital Enablement Named PM360 Trailblazer 2023 Supplier/Vendor of the Year
Rhea-AI Summary
IQVIA (NYSE:IQV) has been named a PM360 Trailblazer 2023 Company of the Year in the Supplier/Vendor category for its Digital Enablement division. The award recognizes outstanding achievement and innovation in healthcare marketing, with a focus on innovation, talent development, and social responsibility.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.33%
Tags
none
-
News
IQVIA CFO Ron Bruehlman to Speak at Evercore HealthCONx Conference on November 29, 2023
Rhea-AI Summary
IQVIA Holdings Inc. (IQV) announced that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Evercore Annual HealthCONx Conference in Miami on November 29, 2023, at 10:50 a.m. ET. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com, with a replay available later that day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
conferences
-
News
IQVIA Announces Upsizing of its Allocation of New Term B Loans
Rhea-AI Summary
IQVIA Holdings Inc. (NYSE:IQV) announces allocation of a new term B loan due 2031 of approximately $1,500 million, upsized due to lender demand. The loan, along with senior secured notes, will be used to repay existing loans and related fees. The Company also entered into a cross-currency swap agreement to hedge exposure to USD-denominated indebtedness, resulting in an effective net borrowing rate of 4.9015%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes
Rhea-AI Summary
IQVIA Holdings Inc. (NYSE:IQV) announces the pricing of $1,250 million in senior secured notes due 2029, which was upsized due to strong demand. The proceeds will be used to repay outstanding term loans and pay fees and expenses related to the offering and credit agreement amendment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.67%
Tags
none
-
News
IQVIA Announces Offering of Senior Secured Notes
Rhea-AI Summary
IQVIA Holdings Inc. (NYSE:IQV) Announces Intent to Raise $500 Million through Notes Offering and Amend Credit Facilities. The proceeds will be used to repay outstanding term loans and pay related fees and expenses. The offering is subject to market conditions and customary terms.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.52%
Tags
none
-
News
IQVIA’s Christina Mack Named 2023 PharmaVoice 100 Honoree
Rhea-AI Summary
IQVIA, a global provider of data and analytics to the life sciences industry, announced that Dr. Christina Mack, chief scientific officer, has been named to the 2023 PharmaVoice 100 list. The list recognizes leaders who have made significant contributions to the industry and improved the lives of patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
none
News
IQVIA Reports Third-Quarter 2023 Results
Rhea-AI Summary
IQVIA Holdings Inc. reported Q3 2023 financial results with revenue of $3,736 million, a 4.9% YoY increase. GAAP Net Income grew 7.1% YoY to $303 million. R&D Solutions quarterly bookings reached $2.6 billion with a book-to-bill ratio of 1.24x. The contracted backlog grew 12% YoY to $28.8 billion. Adjusted EBITDA increased 9.1% YoY to $888 million. The company updated its full-year guidance with a revenue growth range of 3.3% to 3.5%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.45%
Tags
earnings
-
News
IQVIA to Provide Sanofi Its Orchestrated Customer Engagement (OCE) Platform in Africa & Middle East
Rhea-AI Summary
Sanofi will use IQVIA's CRM platform to maximize customer interactions and innovate in the retail channel.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.35%
Tags
none
-
News
IQVIA and CEPI Collaborate to Strengthen Global Research Preparedness to Advance the 100 Days Mission
Rhea-AI Summary
CEPI and IQVIA announce strategic collaboration to advance the 100 Days Mission and strengthen global clinical research for vaccines and biological countermeasures against emerging infectious diseases.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.51%
Tags
none
News
IQVIA to Announce Third-Quarter 2023 Results on November 1, 2023
Rhea-AI Summary
IQVIA Holdings Inc. will announce its Q3 2023 financial results on November 1, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.99%
Tags
earnings
Stock IQV logo
IQVIA Holdings Inc

NYSE:IQV

IQV Rankings

#292 Ranked by Market Cap
#2970 Ranked by Stock Gains
N/A Ranked by Dividends

IQV Stock Data

42.63B
179.80M
0.92%
92.3%
1.59%
Offices of All Other Miscellaneous Health Practitioners
Health Care and Social Assistance
Link
US
Durham

About IQV

quintiles and imshealth have merged together to form the new quintilesims. each wanting to bring something new to customers, we deliver integrated information and technology solutions to drive healthcare forward. quintilesims has approximately 50,000 employees conducting operations in more than 100 countries, dedicated to helping our clients improve their clinical, scientific and commercial results. as a global leader in protecting individual patient privacy, quintilesims uses healthcare data to deliver critical, real-world disease and treatment insights. to learn more, visit www.quintilesims.com